MedTrace Logo

Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism

NCT02977013 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2017-04-04

No results posted yet for this study

Summary

The aim of the present study is to monitor anticoagulant therapy by anti-Xa assay and correlate its level to the efficacy and safety of enoxaparin in the treatment of pulmonary embolism.

Conditions

  • Anti-Xa Assay in Pulmonary Embolism

Interventions

DIAGNOSTIC_TEST

Anti-Xa assay

Correlation between anti-Xa assay and the efficacy and safety of enoxaparin in the treatment of pulmonary embolism

Sponsors & Collaborators

  • Mohamed Sayed Mohamed Abbas

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-09-30
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02977013 on ClinicalTrials.gov